Login

Johan Strid, CEO of Prevas AB, presentation at the 2021 annual meeting focused on strategic initiatives and company performance. 00:10:00

Share On Facebook Share On Twitter

Johan Strid is CEO of the Prevas

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Jonathan Thomas and Primerica Strategic Partner, American Century | Jonathan Thomas, CEO , American Century Investments.
00:10:00
How Diversification Helped Investors Make Money During the Lost Decade | David J. Bromelkamp - CEO of Allodium Investment Consultants
00:10:00
Kyle Floyd Discusses Vox Royalty's Approach and Growth in the Royalty Space
00:10:00
Deborah Gersh on Private Equity Investments in Value-Based Health Care | Deborah L. Gersh - PARTNER of Ropes & Gray LLP
00:10:00
Unlocking Success with Our Technical Advisory Services Team | Rajiv Sharma, Group CEO, Coats Group PLCCOA:LSE
00:10:00
Revolutionizing the retail landscape, innovative solutions to supply chain challenges and compliance management, driving growth and profitability|Randall K. (Randy), CEO, Park City Group, Inc.
00:10:00
From 1994 we Enabling entrepreneurs across emerging markets|Mukul Gulati, President, Zephyr Management, LP
00:10:00
Interview with Hans Wallenstam, CEO of Wallenstam | Hans Wallenstam, CEO, Wallenstam AB.
00:10:00
HighGold Mining: High-Grade Gold Focused in North America, New TSX Venture Listing
00:10:00
Tenable CEO Amit Yoran discusses the ransomware attack on UnitedHealthcare during a CNN interview.
00:10:00
Vantea Smart’s Growth Unveiled at INTEGER SIM Investor Day with Simone Veglioni | Simone Veglioni, CEO , Vantea Smart SPA.
00:10:00
Insider Tips on Investor Relations with Wendy Webb | Wendy Webb, independent director at ABM

© 2026 Nehu